Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Loy Bertrand, Président et CEO. Director active across 4 companies, notably HARVARD BIOSCIENCE INC. Cumulatively, 42 reports have been logged. Split: 4 buys · 5 sells. Total volume traded: €11.3m. History available since 25 May 2021. The latest transaction was filed on 1 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Loy Bertrand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
LOY BERTRAND is Président et CEO. The declarant has 41 filings in total, and across the sampled recent filings from 2016-01-05 to 2026-04-20, the indicated aggregated amounts are EUR 107071 of buys and EUR 11164602 of sells, with modal transaction nature shown as Attribution. They are listed as Executive Chair at ENTEGRIS INC and as Director at Harvard Bioscience INC and HARVARD BIOSCIENCE INC.